+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Oral Vaccine"

Dengue Vaccine Market Opportunities and Strategies to 2034 - Product Thumbnail Image

Dengue Vaccine Market Opportunities and Strategies to 2034

  • Report
  • March 2025
  • 294 Pages
  • Global
From
Live Attenuated Polio Vaccine Global Market Report 2025 - Product Thumbnail Image

Live Attenuated Polio Vaccine Global Market Report 2025

  • Report
  • January 2025
  • 175 Pages
  • Global
From
Aquaculture Vaccines Market - Global Forecast 2025-2032 - Product Thumbnail Image

Aquaculture Vaccines Market - Global Forecast 2025-2032

  • Report
  • October 2025
  • 196 Pages
  • Global
From
From
From
From
From
From
From
From
From
From
From
From
From
From
From
From
Latin America Vaccine Market Report and Forecast 2025-2034 - Product Thumbnail Image

Latin America Vaccine Market Report and Forecast 2025-2034

  • Report
  • June 2025
  • 300 Pages
  • Latin America
From
Loading Indicator

The Oral Vaccine market is a subset of the larger Vaccines market, which is focused on the development and distribution of vaccines to prevent and treat infectious diseases. Oral Vaccines are administered orally, rather than through injection, and are typically used to protect against gastrointestinal infections. These vaccines are often used in developing countries, where access to injection-based vaccines may be limited. Oral Vaccines are also used in certain circumstances where injection-based vaccines may not be suitable, such as in the elderly or immunocompromised individuals. Oral Vaccines are typically composed of weakened or killed pathogens, which stimulate the body’s immune system to produce antibodies against the disease. These vaccines are typically administered in multiple doses, and may require booster shots to maintain immunity. Some companies in the Oral Vaccine market include GlaxoSmithKline, Merck, Sanofi, Pfizer, and Johnson & Johnson. Show Less Read more